Journal article
Patient-important outcomes reported in randomized controlled trials of pharmacologic treatments for COVID-19: a protocol of a META-epidemiological study
Abstract
BackgroundThe coronavirus disease 19 (covid-19) pandemic has underscored the need to expedite clinical research, which may lead investigators to shift away from measuring patient-important outcomes (PIO), limiting research applicability. We aim to investigate if randomized controlled trials (RCTs) of covid-19 pharmacological therapies include PIOs.MethodsWe will perform a meta-epidemiological study of RCTs that included people at risk for, or …
Authors
Jimenez-Mora MA; Varela AR; Meneses-Echavez JF; Bidonde J; Angarita-Fonseca A; Siemieniuk RAC; Zeraatkar D; Bartoszko JJ; Brignardello-Petersen R; Honarmand K
Journal
Systematic Reviews, Vol. 10, No. 1,
Publisher
Springer Nature
Publication Date
December 2021
DOI
10.1186/s13643-021-01838-8
ISSN
2046-4053